An investment of up to $10 million by Piramal Pharma Solutions at Lexington’s Coldstream Laboratories, which develops and manufactures injectable pharmaceuticals, will create 40 new jobs and expand capabilities. India-based Piramal, which purchased Coldstream Labs a year ago, plans to invest in, and expand Coldstream Labs’ manufacturing facility. William Wedlake, president, formulations and antibody drug conjugates (ADC), Piramal Pharma Solutions, said the investment aligns well with the c...